ProfileGDS5822 / ILMN_1258690
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 59% 10% 42% 10% 11% 25% 26% 17% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 127.959
GSM1276600PDAC Late Ablation Control 211.810
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 116.742
GSM1276603PDAC Late Ablation 28.510
GSM1276604PDAC Late Ablation 38.511
GSM1303940PDAC Late Ablation_anti-CTLA4 114.225
GSM1303941PDAC Late Ablation_anti-CTLA4 21326
GSM1303942PDAC Late Ablation_anti-CTLA4 39.317